JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander?

JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander?

Objectives BCR-ABL1 and JAK2 V617F coexistence in myeloproliferative neoplasms has been described as concomitant or sequential events. Despite this, we present a unique case of chronic myeloid leukemia (CML) not referable to either of the known scenarios.Methods BCR-ABL1 molecular monitoring was per...

Full description

Bibliographic Details
Main Authors: Francesco Tarantini, Cosimo Cumbo, Antonella Zagaria, Elisa Parciante, Luisa Anelli, Nicoletta Coccaro, Giuseppina Tota, Crescenzio Francesco Minervini, Immacolata Redavid, Antonella Russo Rossi, Maria Rosa Conserva, Giorgina Specchia, Pellegrino Musto, Francesco Albano
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Hematology
Subjects:
Chronic myeloid leukemia
JAK2
CHIP
BCR-ABL1
TFR
biological age
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2022.2108902

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2022.2108902

Similar Items